tiprankstipranks
Medexus Pharmaceuticals (TSE:MDP)
:MDP
Canadian Market

Medexus Pharmaceuticals Inc (MDP) Income Statement

Compare
56 Followers

Medexus Pharmaceuticals Inc Income Statement

Last quarter (Q2 2024), Medexus Pharmaceuticals Inc's total revenue was C$26.30M, a decrease of -13.27% from the same quarter last year. In Q2, Medexus Pharmaceuticals Inc's net income was C$110.00K. See Medexus Pharmaceuticals Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
C$ 113.05MC$ 108.10MC$ 76.70MC$ 79.66MC$ 52.43M
Gross Profit
C$ 59.51MC$ 60.04MC$ 37.93MC$ 42.01MC$ 29.44M
Operating Expenses
C$ 48.72MC$ 51.55MC$ 50.30MC$ 41.27MC$ 30.48M
Depreciation and Amortization
C$ 5.81MC$ 8.05MC$ 7.71MC$ 7.90MC$ 5.26M
EBITDA
C$ 19.28MC$ 14.65MC$ 15.16MC$ -23.61MC$ 7.04M
Operating Income
C$ 10.79MC$ 7.61MC$ -15.00MC$ -1.38M-
Other Income/Expenses
C$ -10.69MC$ -12.65MC$ 11.18MC$ -30.13MC$ 244.00K
Pretax Income
C$ 106.00KC$ -5.04MC$ -3.82MC$ -31.50M-
Net Income
C$ -214.00KC$ 1.22MC$ -2.88MC$ -28.26M-
Per Share Metrics
C$ ―C$ ―C$ ―C$ ―C$ ―
Basic EPS
C$ -0.01C$ 0.06C$ -0.15C$ -1.86C$ -0.31
Diluted EPS
C$ -0.01C$ 0.06C$ -0.14C$ -1.86C$ -0.31
Weighted Average Shares Outstanding
22.32M 19.98M 19.45M 15.20M 14.36M
Weighted Average Shares Outstanding (Diluted)
22.49M 20.52M 19.86M 15.20M 14.36M
Currency in CAD

Medexus Pharmaceuticals Inc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis